Japan Animal Referral Medical Center Co., Ltd. (JP:6039)
:6039
Top Page
Japan Animal Referral Medical Center Co., Ltd.
(6039)
Select Model
Select Model
Rating:79Outperform
Price Target:
¥1,469.00
▲(25.02% Upside)
Action:ReiteratedDate:02/21/26
The score is driven primarily by strong financial performance (rapid revenue growth, improving margins, and materially better cash flow) and a clear positive technical trend (price above key moving averages with positive MACD). This is partially offset by a less attractive valuation profile (P/E 23.55 and a low 0.51% dividend yield).
Positive Factors
Specialized referral business model
A referral-focused model concentrates complex, higher-value cases that general clinics cannot treat. This specialization supports durable pricing power, higher per-case margins, and clinical barriers to entry, enabling sustainable differentiation and repeat referral flows over time.
Negative Factors
Moderate leverage
A debt-to-equity ratio near 0.84 signals meaningful reliance on borrowings. Over the medium term this can constrain financial flexibility for expansion or acquisitions, raise interest exposure, and reduce resilience to revenue shocks compared with more conservatively financed peers.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialized referral business model
A referral-focused model concentrates complex, higher-value cases that general clinics cannot treat. This specialization supports durable pricing power, higher per-case margins, and clinical barriers to entry, enabling sustainable differentiation and repeat referral flows over time.
Read all positive factors
Japan Animal Referral Medical Center Co., Ltd. (6039) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥20.88B
Dividend Yield0.64%
Average Volume (3M)24.65K
Price to Earnings (P/E)14.5
Beta (1Y)0.53
Revenue Growth18.22%
EPS Growth47.81%
CountryJP
Employees256
SectorConsumer Cyclical
Sector Strength84
IndustryPersonal Products & Services
Share Statistics
EPS (TTM)20.26
Shares Outstanding14,391,000
10 Day Avg. Volume16,500
30 Day Avg. Volume24,646
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)1.61
Price to Sales (P/S)1.27
P/FCF Ratio15.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)77.38
Revenue Forecast (FY)¥6.70B
Japan Animal Referral Medical Center Co., Ltd. Business Overview & Revenue Model
Company Description
Japan Animal Referral Medical Center Co., Ltd. owns and operates medical centers for animals in Japan. Its veterinary hospital provides advanced medical care service for dogs and cats. The company's medical center comprises cardiology, respiratory...
How the Company Makes Money
null...
Japan Animal Referral Medical Center Co., Ltd. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
82
Very Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.50B | 5.28B | 4.27B | 3.87B | 2.98B | 2.85B |
| Gross Profit | 1.97B | 1.81B | 1.43B | 1.41B | 1.07B | 977.09M |
| EBITDA | 1.41B | 1.29B | 961.39M | 996.73M | 680.27M | 625.58M |
| Net Income | 598.24M | 520.98M | 337.22M | 380.66M | 286.94M | 285.19M |
Balance Sheet | ||||||
| Total Assets | 9.09B | 8.75B | 8.77B | 8.58B | 7.11B | 5.84B |
| Cash, Cash Equivalents and Short-Term Investments | 1.22B | 1.11B | 1.34B | 1.92B | 1.07B | 1.21B |
| Total Debt | 3.86B | 3.48B | 3.86B | 3.98B | 3.92B | 3.07B |
| Total Liabilities | 4.86B | 4.61B | 4.96B | 4.87B | 4.60B | 3.51B |
| Stockholders Equity | 4.23B | 4.15B | 3.81B | 3.71B | 2.51B | 2.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 418.70M | -141.26M | 82.62M | -44.14M | 438.89M |
| Operating Cash Flow | 0.00 | 1.37B | 899.78M | 810.92M | 557.57M | 504.39M |
| Investing Cash Flow | 0.00 | -994.38M | -985.86M | -784.07M | -1.43B | -69.57M |
| Financing Cash Flow | 0.00 | -608.03M | -392.32M | 820.59M | 722.09M | -469.43M |
Japan Animal Referral Medical Center Co., Ltd. Technical Analysis
Positive
1175.00
Price Trends
1287.36
Positive
1217.51
Positive
979.43
Positive
Market Momentum
13.12
Negative
65.40
Neutral
96.80
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6039, the sentiment is Positive. The current price of 1175 is below the 20-day moving average (MA) of 1255.97, below the 50-day MA of 1287.36, and above the 200-day MA of 979.43, indicating a bullish trend. The MACD of 13.12 indicates Negative momentum. The RSI at 65.40 is Neutral, neither overbought nor oversold. The STOCH value of 96.80 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6039.
Japan Animal Referral Medical Center Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
JP:6039
Japan Animal Referral Medical Center Co., Ltd.
1,456.00
974.79
202.57%
JP:9628
San Holdings, Inc. (Japan)
1,413.00
277.73
24.46%
Japan Animal Referral Medical Center Co., Ltd. Corporate Events
Japan Animal Referral Medical Center Delivers Strong Nine-Month Earnings and Confirms Growth Outlook
Feb 17, 2026
Japan Animal Referral Medical Center reported strong results for the nine months ended December 31, 2025, with net sales rising 18.2% year on year to ¥4,660 million and profit attributable to owners of parent jumping 65.0% to ¥675 millio...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.